In general, complements C4 and C3 consumption has been observed in septic patients, which is mirrored in the generation of increased levels of complement activation products, including the anaphylatoxins C4a, C3a, and C5a that are associated with severity and mortality in sepsis [27, 28, 29, 30, 31, 32]. This evidence concerns the gene C4A and Sepsis.